2 top ASX Healthcare shares to watch for 2020

While the CSL Ltd (ASX: CSL) share price is making new highs, investors should turn their heads to watch Nanosonics Ltd (ASX: NAN) and Volpara Health Technologies Ltd (ASX: VHT).

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The ASX200 is potentially witnessing a transition from growth to value shares. This has seen household names such as Afterpay Touch Group Ltd (ASX: APT), Appen Ltd (ASX: APX) and Altium Limited (ASX: ALU) and more, down by more than 20%. However, many names in the healthcare space have remained unscathed.

Here are 2 ASX healthcare shares that could make leaps and bounds in 2020.

1. Nanosonics Ltd (ASX: NAN)

Nanosonics has become a household name in the healthcare sector and as a leading ASX growth stock. Some have even described it as the next CSL Limited (ASX: CSL). What makes Nanosonics an exciting growth prospect is not what it has done, but where it will go next.

The company's products have become a standard of care in the Australian and New Zealand market, with approximately 75% market penetration. However, when it comes to regions such as Asia Pacific, Europe and the Middle East, Nanosonics has less than a 4% market penetration. A significant opportunity remains.

In FY20, the company expects to expand its geographical reach and adoption in Europe following positive hospital trials and new Ministry of Health guidelines in France, and Managed Equipment Service growth in the UK. Nanosonics also expects Japan to become a vital growth market as clinical studies demonstrated that over 90% of probes were contaminated.

While the Nanosonics share price is currently near record highs, this is certainly a stock I would buy on a pullback.

2. Volpara Health Technologies Ltd (ASX: VHT)

Volpara is a software-as-a-service (SaaS) medical technology company whose AI imaging algorithms assist the early detection of breast cancer. The company is making leaps and bounds in terms of its usage in the United States (US) and its global footprint.

In Volpara's Q2 FY20 market update, it cited that it remains on track to achieve its forecast of 27% of US women having a group product applied on their images and data. Based on its current estimate, there are currently 25.8% of screened US women (approximately 10.1 million women) using at least 1 Volpara or MRS product. The update suggested that Q2 is traditionally Volpara's weakest quarter for sales. However, Q2's cash receipts increasing by 190% on the prior period is very encouraging.

The company's unique products have created a first mover advantage in the US. It also has major trials underway within the UK and Netherlands, as well as a strong private uptake in Australia and New Zealand.

While Volpara is an excellent growth story, its share price is volatile and currently down more than 4% at the time of writing. The opportunity is one that is more high risk/reward in nature, and I would wait for the share price to consolidate before considering it as a buying opportunity.

Lina Lim has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Nanosonics Limited, Starpharma Holdings Limited, and VOLPARA FPO NZ. The Motley Fool Australia has recommended Nanosonics Limited, Starpharma Holdings Limited, and VOLPARA FPO NZ. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ Shares to Watch

asx share price rebound represented by wooden blocks spelling rebound with coins on top
⏸️ Shares to Watch

Could the Zip (ASX:Z1P) share price make a comeback in 2021? 

The Zip (ASX: Z1P) share price struggled to outperform in the second half of 2020. Could 2021 be a better…

Read more »

⏸️ Shares to Watch

What next for the a2 Milk (ASX:A2M) share price?

Could you call the A2 Milk Company Ltd (ASX: A2M) share price a cheap growth stock after it slumped to…

Read more »

⏸️ Shares to Watch

What's in store for the Afterpay (ASX:APT) share price in 2021? 

The Afterpay (ASX: APT) share price has surged more than 275% in 2020. Here's a little of what investors can…

Read more »

wondering about asx share price represented by man surrounded by question marks
⏸️ Shares to Watch

Is the Zip (ASX:Z1P) share price a buy yet?

The Zip Co Ltd (ASX: Z1P) share price continues to underperform despite an exciting capital raising. Could it finally be…

Read more »

questioning whether asx share price is a buy represented by man in red shirt scratching his head
⏸️ Shares to Watch

Should you buy the Appen (ASX:APX) share price dip?

Could the Appen Ltd (ASX: APX) share price be a buying opportunity after its recent selloff? We take a look…

Read more »

Share Fallers

Why this broker thinks it's time to buy Qantas (ASX:QAN) shares

As state borders re-open to domestic tourism, this broker thinks it could be time to start buying Qantas Airways Limited…

Read more »

wondering about asx share price represented by man surrounded by question marks
⏸️ Shares to Watch

Could this be why the Zip (ASX:Z1P) share price is underperforming?

Could this be why the Zip Co Ltd (ASX: Z1P) share price is down 50% from its August highs and…

Read more »

Hands grabbing for high rung on a ladder pointing to the sky
⏸️ Shares to Watch

The Rhipe (ASX:RHP) share price has jumped 8% today. Here's why.

The Rhipe Ltd (ASX: RHP) share price has popped 8.59% after announcing its first quarter FY21 update. Here's the run…

Read more »